Our news You searched for «oncocross»

4P-Pharma and Oncocross, a Korea-based AI biotech,  signed a research collaboration agreement at the Institut Pasteur de Lille on October 25th, 2021. The two companies will join their expertise to bring an innovative therapeutic agent to the patients affected by Systemic Scleroderma, a rare autoimmune disease affecting the skin and internal organs that has no approved&hellip

On World Rare Disease Day, our team stands together to show support for those who suffer from rare diseases. For the past ten years, our company has been conducting research on three new therapeutic solutions to improve the lives of rare disease patients. The first project involves developing an AI platform-based treatment for systemic sclerosis&hellip